About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

49 Jurimetrics 343 (2008-2009)
Eligibility of Athletes Receiving Necessary Gene Therapy: The Oscar Pistorius Case as Procedural Precedent

handle is hein.journals/juraba49 and id is 349 raw text is: 




















              ELIGIBILITY OF ATHLETES
   RECEIVING NECESSARY GENE THERAPY:
             THE OSCAR PISTORIUS CASE
             AS PROCEDURAL PRECEDENT

                          Blair H. Moses*

ABSTRACT: The recent 2008 Olympics revived the controversy over gene
doping-the non-therapeutic use of genetic material to enhance athletic per-
formance-and the regulations prohibiting its use by athletes. Regulations
against gene doping were instituted by the International Olympic Committee
in 2003 and by the World Anti-Doping Agency in 2004. The regulations ban
only those athletes utilizing gene doping, but the differentiation of gene ther-
apy-the therapeutic use of genetic material-from gene doping can be diffi-
cult. Future athletes receiving gene therapy for valid reasons, such as repairing
sports injuries, also could be banned. The recent Oscar Pistorius case substan-
tiated this concern. Pistorius, who has two artificial legs, was initially banned
from competing in the 2008 Olympics. Even though his prosthetic legs are
therapeutic uses of technology, the International Association of Athletics Fed-
erations ruled they were a technical enhancement that disqualified him from
competing. Pistorius appealed the decision to the Court of Arbitration for
Sports (CAS), whose recent ruling in his favor allows him to compete interna-
tionally against able-bodied runners. Although prosthetic devices are a dif-
ferent form of therapy than gene therapy, the Pistorius case serves as important
procedural precedent for how regulatory agencies might analyze individuals
who have been treated using gene therapy. In particular, four elements from
the CAS decision are relevant for analyzing future alleged gene doping viola-
tions where the enhancement actually results from legitimate gene therapy.

    *J.D. Candidate, Pedrick Scholar, Strouse Scholar, and Law, Science, and Technology Cen-
ter Scholar, Sandra Day O'Connor College of Law, Arizona State University; B.S., 1977, summa
cum laude, Medical Technology, University of Nebraska Medical Center.


SPRING 2009

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most